Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The effects of intrathecal rituximab on biomarkers in multiple sclerosis.
[Optical coherence tomography in multiple sclerosis].
Assessment of confirmed urinary tract infection in patients treated with dalfampridine for multiple sclerosis.
Mapi Pharma granted United States patent covering glatiramer depot for multiple sclerosis
Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis.
Sensitivity and specificity of SWI venography for detection of cerebral venous alterations in multiple sclerosis.
Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS.
Multiple sclerosis: Spinal cord grey matter loss correlates with disability in MS.
Materials for stem cell factories of the future.
A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01.
Vinpocetine inhibits oligodendroglial precursor cell differentiation.
Potential T cell epitopes of Mycobacterium tuberculosis that can instigate molecular mimicry against host: implications in autoimmune pathogenesis.
From "Wheelchair Circuit" to "Wheelchair Assessment Instrument for People with Multiple Sclerosis": Reliability and Validity Analysis of a Test to Assess Driving Skills in Manual Wheelchair Users With Multiple Sclerosis.
MRI in multiple sclerosis: a review of the current literature.
Early Growth Response Gene-2 Controls IL-17 Expression and Th17 Differentiation by Negatively Regulating Batf.
Associations between changes in ferritin levels and susceptibility-weighted imaging filtered phase in patients with relapsing-remitting multiple sclerosis over 24weeks of therapy with subcutaneous interferon beta-1a three times weekly.
Ampyra (dalfampridine) medication guide
B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.
Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus.
Early signs of memory impairment among multiple sclerosis patients with clinically isolated syndrome.
Varicella-zoster virus acute myelitis in a patient with MS treated with natalizumab.
New data at ENS show Novartis drug Gilenya benefited patients by improving all four key measures of multiple sclerosis
Don't stress about it!: Is stress management a disease-modifying therapy for multiple sclerosis?
Distinct profiles of myelin distribution along single axons of pyramidal neurons in the neocortex.
Genmab collaborator GSK starts new ofatumumab Phase III study in rare skin disorder

Pages